Stressnor 1 mg
CNS preparations (Anxiolytics, sedatives & hypnotics)
Composition
- Alprazolam 1mg
Dosage form
- Tablets
Therapeutic Indication
-
Stressnor is indicated for the short-term treatment of moderate or severe anxiety states and anxiety associated with depression. It is only indicated when the disorder is severe, disabling or subjecting the individual to extreme distress.
Stressnor should not be used to treat short-term mild anxiety, such as anxiety or tension associated with the stress of everyday life. As the efficacy of
Stressnor in depression and in phobic or obsessional states has yet to be established, specific treatment may have to be considered.
Dosage and route of administration
-
Anxiety
250 micrograms (0.25
mg) to 500
micrograms (0.5 mg) three times daily, increasing if
required to a total of 3 mg daily.
The elderly or in the presence of debilitating disease 250 micrograms (0.25 mg) two to three times
daily to be gradually increased if needed and tolerated.
If side-effects occur, the dose should be lowered. It is advisable to review treatment regularly and to discontinue use as soon as possible.
Should longer term treatment be necessary, then intermittent treatment may be considered to minimize the risk of dependence.
Paediatric population The safety and efficacy of alprazolam in children and adolescents below the age of 18 years
have not been established. No data are available.
Package
- Carton box containing 1,2,3 (AL/transparent PVC) strips, each of 10 tablets + inner leaflet
